Your browser doesn't support javascript.
loading
Primary central nervous system vasculitis mimicking brain tumor: Comprehensive analysis of 13 cases from a single institutional cohort of 191 cases.
Salvarani, Carlo; Brown, Robert D; Christianson, Teresa J H; Huston, John; Morris, Jonathan M; Giannini, Caterina; Hunder, Gene G.
Affiliation
  • Salvarani C; The Department of Neurology, Mayo Clinic, Rochester, MN, USA; Rheumatology Division, Azienda USL-IRCCS di Reggio Emilia e Università di Modena e Reggio Emilia, Reggio Emilia, Italy. Electronic address: salvarani.carlo@ausl.re.it.
  • Brown RD; The Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Christianson TJH; The Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Huston J; The Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Morris JM; The Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Giannini C; The Department of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.
  • Hunder GG; Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
J Autoimmun ; 97: 22-28, 2019 02.
Article in En | MEDLINE | ID: mdl-30528173
ABSTRACT

OBJECTIVE:

To describe the clinical, laboratory, and imaging features and course of patients with primary central nervous system vasculitis (PCNSV) presenting with an intracranial tumor-like mass (TLM).

METHODS:

We retrospectively studied a cohort of 191 consecutive patients with PCNSV seen at the Mayo Clinic, Rochester, MN over a 35-year period (1982-2017). 13/191 patients presented with a TLM. We compared the findings in these 13 patients with those from the 178 without this presentation.

RESULTS:

In 13 of 191 (6.8%) patients with TLM the diagnosis of PCNSV was established by cerebral biopsy. Granulomatous vasculitis was found in 11/13 patients, accompanied by vascular deposits of ß-amyloid peptide in 7. Compared to the 178 patients without TLM, the patients with TLM were more likely to be male (p = 0.04), and less likely to have a transient ischemic attack (p = 0.023), bilateral cerebral infarcts (p = 0.018), or vasculitic lesions on angiography (p = 0.045). They were more likely to have seizures (p = 0.022), gadolinium-enhanced lesions (p = 0.007), and amyloid angiopathy (p = 0.046). All 13 patients responded to therapy and 8/13 (61.5%) had a Rankin disability score of 0 at last visit. Overall, high disability scores (Rankin scores 4-6) at last follow-up were associated with increasing age (odds ratio, OR, 1.49) and cerebral infarction (OR, 3.47), but were less likely in patients with gadolinium-enhanced lesions (OR, 0.36) and amyloid angiopathy (OR, 0.21).

CONCLUSION:

In PCNSV a TLM at presentation represents a definable subgroup of patients with a favourable treatment response.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Vasculitis, Central Nervous System Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Autoimmun Journal subject: ALERGIA E IMUNOLOGIA Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Vasculitis, Central Nervous System Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Autoimmun Journal subject: ALERGIA E IMUNOLOGIA Year: 2019 Type: Article